老年急性冠脉综合征患者早期侵入性与保守策略:一项Meta分析
该系统评价与Meta分析纳入将70岁及以上急性冠脉综合征患者随机分配至早期侵入策略或保守管理的试验,排除观察性分析,检索至2024年10月。汇总分析显示两组全因死亡无显著差异(RR 1.05,95%CI 0.98-1.11,P=.15,I²=0%)。早期侵入策略与再发心梗风险降低22%(RR 0.78,95%CI 0.67-0.91,P=.001,I²=0%)及随访期间再次冠脉血运重建风险降低57%(RR 0.43,95%CI 0.30-0.60,P<.001,I²=33.3%)相关,但与大出血风险增加相关(RR 1.60,95%CI 1.01-2.53,P=.046,I²=16.7%)。非ST段抬高型ACS人群结果与总体一致。作者认为,在为老年ACS患者共同决策时应权衡早期侵入策略相关的竞争风险。
要点
- 70岁及以上ACS患者中,早期侵入策略与保守策略的全因死亡无显著差异:RR 1.05(95%CI 0.98-1.11,P=.15,I²=0%)。
- 早期侵入策略使再发心梗风险降低22%:RR 0.78(95%CI 0.67-0.91,P=.001,I²=0%)。
- 早期侵入策略使随访期间再次冠脉血运重建风险降低57%:RR 0.43(95%CI 0.30-0.60,P<.001,I²=33.3%)。
- 早期侵入策略与大出血风险增加相关:RR 1.60(95%CI 1.01-2.53,P=.046,I²=16.7%)。
- 纳入试验的样本量加权平均年龄82.6岁,46%为女性;非ST段抬高型ACS人群结果与总体一致。
适用人群与场景
- 年龄70岁及以上、表现为急性冠脉综合征的患者,纳入随机分配至早期侵入策略或保守管理的试验。
- 排除观察性分析;未基于样本量或随访时长排除试验。
研究设计与关键结果
- 研究类型:系统评价与Meta分析,纳入将70岁及以上ACS患者随机分配至早期侵入策略或保守管理的试验,排除观察性分析。
- 样本量加权平均年龄82.6岁,46%为女性。
- 主要终点全因死亡:早期侵入策略 vs 保守策略 RR 1.05(95%CI 0.98-1.11,P=.15,I²=0%),无显著差异。
- 再发心梗:RR 0.78(95%CI 0.67-0.91,P=.001,I²=0%),早期侵入策略风险降低22%。
- 随访期间再次冠脉血运重建:RR 0.43(95%CI 0.30-0.60,P<.001,I²=33.3%),早期侵入策略风险降低57%。
- 大出血:RR 1.60(95%CI 1.01-2.53,P=.046,I²=16.7%),早期侵入策略风险增加。
- 其他次要终点(心血管死亡、死亡或心梗、卒中、心衰住院、主要不良心脏事件、主要不良心脑血管事件、住院时长)未见差异。
- 非ST段抬高型ACS人群结果与总体一致。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,仅纳入随机对照试验,排除观察性分析。
- 采用固定效应与随机效应模型计算相对风险(RR)与风险比(HR)及95%CI。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在老年ACS患者的共同治疗决策中,应权衡早期侵入策略相关的竞争风险(减少再发心梗与再次血运重建 vs 增加大出血)。
- 原文结论提示,早期侵入策略与保守管理相比未降低全因死亡,临床决策需结合缺血与出血风险个体化评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The optimal management strategy for older patients who present with acute coronary syndrome (ACS) remains unclear due to a paucity of randomized evidence. New large and longer-term randomized data are available.
OBJECTIVE: To test the association of an early invasive strategy vs a conservative strategy with clinical outcomes for patients 70 years or older who present with ACS.
DATA SOURCES: A literature search strategy was designed in collaboration with a medical librarian. MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were systematically searched ,with no language restrictions from inception through October 2024. Bibliographies of previous reviews and conference abstracts from major cardiovascular scientific meetings were handsearched.
STUDY SELECTION: Studies were deemed eligible following review by 2 independent, masked investigators if they randomly allocated patients 70 years or older who presented with ACS to early invasive or conservative management and reported clinical end points. Observational analyses were excluded. No trials were excluded based on sample size or follow-up duration.
DATA EXTRACTION AND SYNTHESIS: Data were extracted independently and in triplicate. Clinical end points were pooled in meta-analyses that applied fixed-effects and random-effects modeling to calculate summary estimates for relative risks (RRs) and hazard ratios, along with their corresponding 95% CIs.
MAIN OUTCOMES AND MEASURES: The prespecified primary end point was all-cause death. Secondary end points included recurrent myocardial infarction (MI), repeated coronary revascularization, major bleeding, cardiovascular death, death or MI, stroke, heart failure hospitalization, major adverse cardiac events, major adverse cardiovascular or cerebrovascular events, and length of hospital stay.
RESULTS: The sample size-weighted mean age of participants across included trials was 82.6 years, and 46% were female. In the pooled analysis, there was no significant difference in all-cause death between the invasive and conservative strategies (RR, 1.05; 95% CI, 0.98-1.11; P = .15; I2 = 0%). An early invasive strategy was associated with a reduced risk of recurrent MI of 22% (RR, 0.78; 95% CI, 0.67-0.91; P = .001; I2 = 0%) and repeated coronary revascularization during follow-up of 57% (RR, 0.43; 95% CI, 0.30-0.60; P < .001; I2 = 33.3%). However, an invasive strategy was associated with an increased risk of major bleeding (RR, 1.60; 95% CI, 1.01-2.53; P = .046; I2 = 16.7). No differences were observed in secondary end points. Results in the non-ST-elevation ACS population were consistent with the overall findings.
CONCLUSIONS AND RELEVANCE: The results of this systematic review and meta-analysis suggest that, in older patients with ACS, an early invasive strategy was not associated with reduced all-cause death compared with conservative management. An early invasive strategy was associated with reduced recurrent MI and repeated coronary revascularization during follow-up but increased risk of major bleeding. Competing risks associated with an early invasive strategy should be weighed in shared therapeutic decision-making for older patients with ACS.
参考来源
- Reddy RK, Koeckerling D, Eichhorn C, et al. Early Invasive or Conservative Strategies for Older Patients With Acute Coronary Syndromes: A Meta-Analysis. JAMA Intern Med. 2025. PMID: 40549394. doi:10.1001/jamainternmed.2025.2058
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。